Clinical Trials Browser

Recurrence × etoposide phosphate × Clear all

NCT01356290 2026-02-23

MEMMAT

Phase 2 Recruiting

Ependymoma, Medulloblastoma, Recurrence

NCT00788125 2023-07-14

Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors

Phase 1/2 Terminated

7 enrolled 9 charts

CNSGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Familial ependymoma, Ovarian Germ Cell Cancer, Testicular Germ Cell Tumor, Astrocytoma, Burkitt Lymphoma, Carcinoma, Renal Cell, Immunoblastic Lymphadenopathy, Kidney Neoplasms, Liver Neoplasms, Lymphoma, Medulloblastoma, Wilms Tumor, Neuroblastoma, Oligodendroglioma, Ovarian Neoplasms, Recurrence, Sarcoma, Osteosarcoma, Spinal Cord Neoplasms, Teratoma, Testicular Neoplasms, Lymphoma, Large B-Cell, Diffuse, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Lymphoma, Large-Cell, Anaplastic, Nephroma, Mesoblastic, Neuroectodermal Tumors, Primitive, Peripheral, Rhabdoid Tumor, Optic Nerve Glioma, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating

NCT01411267 2022-04-04

AC220 for Children With Relapsed/Refractory ALL or AML

Phase 1 Completed

24 enrolled 14 charts

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Myeloid, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00981799 2020-10-01

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Phase 1/2 Terminated

23 enrolled 12 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Recurrence, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00939653 2020-02-19

T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML)

Phase 2 Terminated

6 enrolled 10 charts

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT02015728 2016-12-15

SEED

Phase NA Unknown

Neoplasms, Recurrence

NCT00070187 2013-10-17

Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma

Phase 2/3 Completed

Hodgkin Disease, Lymphoma, Recurrence

NCT00776802 2013-06-25

GCS-100LE

Phase 1/2 Withdrawn

Recurrence, Lymphoma, Large B-Cell, Diffuse